These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30526328)

  • 1. Disease course patterns in systemic lupus erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    Lupus; 2019 Jan; 28(1):114-122. PubMed ID: 30526328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monophasic Disease Course in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    J Rheumatol; 2018 Aug; 45(8):1131-1135. PubMed ID: 29858240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged clinical remission in patients with systemic lupus erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Papneja A; Gladman DD
    J Rheumatol; 2014 Sep; 41(9):1808-16. PubMed ID: 25086082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
    Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
    Tselios K; Gladman DD; Touma Z; Su J; Anderson N; Urowitz MB
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):822-828. PubMed ID: 30055090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus.
    Sato JO; Corrente JE; Saad-Magalhães C
    Lupus; 2015 Nov; 24(13):1421-8. PubMed ID: 26253073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years.
    Taraborelli M; Cavazzana I; Martinazzi N; Lazzaroni MG; Fredi M; Andreoli L; Franceschini F; Tincani A
    Lupus; 2017 Oct; 26(11):1197-1204. PubMed ID: 28420047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients.
    Abdelrahman N; Beresford MW; Leone V;
    Lupus; 2019 Apr; 28(5):667-674. PubMed ID: 30943853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged remission in systemic lupus erythematosus.
    Urowitz MB; Feletar M; Bruce IN; Ibañez D; Gladman DD
    J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.
    Reátegui-Sokolova C; Rodríguez-Bellido Z; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Cucho-Venegas M; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2019 Oct; 28(11):1344-1349. PubMed ID: 31551028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Fasano S; Margiotta DPE; Pierro L; Navarini L; Riccardi A; Afeltra A; Valentini G
    Clin Rheumatol; 2019 Feb; 38(2):457-463. PubMed ID: 30194649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.
    Petri M; Magder LS
    Arthritis Rheumatol; 2018 Nov; 70(11):1790-1795. PubMed ID: 29806142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Low Disease Activity in Systemic Lupus Erythematosus.
    Polachek A; Gladman DD; Su J; Urowitz MB
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):997-1003. PubMed ID: 27696791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre.
    Lim SC; Chan EWL; Tang SP
    Lupus; 2020 Aug; 29(9):1106-1114. PubMed ID: 32631203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.
    Nikpour M; Urowitz MB; Ibañez D; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1152-8. PubMed ID: 19714602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.